|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0030705,
umls-concept:C0039195,
umls-concept:C0185117,
umls-concept:C0757457,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2239176,
umls-concept:C2911684,
umls-concept:C2911692
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-11-17
|
|
pubmed:abstractText |
Multidrug resistance-associated protein 3 (MRP3) is a carrier-type transport protein belonging to the ABC transporters. It is expressed in normal tissues, and enhanced expression in many cancers has been reported. In this study, we investigated the usefulness of MRP3 as a target antigen in immunotherapy for hepatocellular carcinoma (HCC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
946-54
|
|
pubmed:meshHeading |
pubmed-meshheading:18619700-Aged,
pubmed-meshheading:18619700-Biopsy,
pubmed-meshheading:18619700-CD8-Positive T-Lymphocytes,
pubmed-meshheading:18619700-Carcinoma, Hepatocellular,
pubmed-meshheading:18619700-Cell Line, Tumor,
pubmed-meshheading:18619700-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:18619700-Female,
pubmed-meshheading:18619700-Flow Cytometry,
pubmed-meshheading:18619700-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18619700-Humans,
pubmed-meshheading:18619700-Immunotherapy,
pubmed-meshheading:18619700-Interferon-gamma,
pubmed-meshheading:18619700-Liver,
pubmed-meshheading:18619700-Liver Neoplasms,
pubmed-meshheading:18619700-Male,
pubmed-meshheading:18619700-Middle Aged,
pubmed-meshheading:18619700-Multidrug Resistance-Associated Proteins,
pubmed-meshheading:18619700-RNA, Messenger,
pubmed-meshheading:18619700-T-Lymphocytes, Cytotoxic
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Expression of multidrug resistance-associated protein 3 and cytotoxic T cell responses in patients with hepatocellular carcinoma.
|
|
pubmed:affiliation |
Department of Gastroenterology, Graduate School of Medicine, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan.
|
|
pubmed:publicationType |
Journal Article
|
